Analyst Calls

Pharmacor analyst calls are available exclusively to clients who subscribe to the Pharmacor advisory service being featured in the online presentation. Recordings of the presentations are also available for playback following each session. Topics covered in Pharmacor analyst calls include detailed and timely analysis on:

• How a newly launched drug will compete in the market and how it will impact the market share of other currently marketed therapies
• What the impact of corporate announcements and presentations at biopharmaceutical conferences will have on the marketplace
• How a drug’s regulatory rejection will impact the market, including insight on what other existing therapies will inherit the failed agent’s market share
• How positive clinical trial data will impact thought leaders’ perceptions of a drug candidate and how that agent would be prescribed if approved
• How a market currently dominated by a certain drug class will evolve as emerging therapies from other drug classes steal share from dominant therapies over time
• Which agents in a crowded therapeutic pipeline are best positioned to have the greatest impact on treatment and, as a result, will be the most successful

• Landmark Findings from the European Society of Cardiology Congress - Assessing Xarelto’s Potential to Streamline the Treatment of VTE - Upcoming
  September 10, 2010

  Based on our Pharmacor advisory service entitled Venous Thromboembolism, Decision Resources is offering an exclusive analyst call entitled Landmark Findings from the European Society of Cardiology Congress - Assessing Xarelto’s Potential to Streamline the Treatment of VTE. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
   

  This analyst call will be held on September 10, 2010. Contact us to learn how you can purchase this service and attend the call.
  
  Click here to view the invite.
  
  
  Read More
• Potential Blockbuster Derailed: Eli Lilly Discontinues Development of Semagacestat for Alzheimer’s Disease - Upcoming
  September 8, 2010

  Based on our Pharmacor advisory service entitled Alzheimer’s Disease, Decision Resources is offering an exclusive analyst call entitled Potential Blockbuster Derailed: Eli Lilly Discontinues Development of Semagacestat for Alzheimer’s Disease. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
   

  This analyst call will be held on September 8, 2010. Contact us to learn how you can purchase this service and attend the call.
  
  Click here to view the invite.
  
  
  Read More
• In Light of Safety Concerns, Abbott’s Briakinumab Faces a Rough Road Ahead in the Psoriasis Drug Market - Upcoming
  September 7, 2010

  Based on our Pharmacor advisory service entitled Psoriasis, Decision Resources is offering an exclusive analyst call entitled In Light of Safety Concerns, Abbott’s  Briakinumab Faces a Rough Road Ahead in the Psoriasis Drug Market. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  

  This analyst call will be held on September 7, 2010. Contact us to learn how you can purchase this service and attend the call.
  
  Click here to view the invite.
  
  
  
  Read More
• How Will Physician Acceptance of Biosimilars Vary by Specialty? - On Demand
  August 18, 2010
  As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive analyst call entitled How Will Physician Acceptance of Biosimilars Vary by Specialty? This analyst call is open ONLY to subscribers of Decision Resources’ Biosimilars Advisory Service.
  
  This analyst call was held on August 18, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  
  Click here to view the invite.
  
  
  Read More
• The New HIV Pipeline: Where Have All the Drugs Gone and Has Virological Failure Doomed Rilpivirine’s Status as a Rising Star? - On Demand
  August 4, 2010
  Based on our Pharmacor advisory service entitled Human Immunodeficiency Virus, Decision Resources is offering an exclusive analyst call entitled The New HIV Pipeline: Where Have All the Drugs Gone and Has Virological Failure Doomed Rilpivirine’s Status as a Rising Star?  Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  This analyst call was held on August 4, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
   
  
  Read More
• Who Will Be the Winners and Losers in the Obesity Wars? Fallout from the FDA Advisory Committee’s Vote on Qnexa - On Demand
  August 3, 2010
  Based on our Pharmacor advisory service entitled Obesity, Decision Resources is offering an exclusive analyst call entitled Who Will Be the Winners and Losers in the Obesity Wars? Fallout from the FDA Advisory Committee’s Vote on Qnexa.  Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  This analyst call was held on August 3, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
   
  
  Read More
• A Crushing Blow for Avastin? Assessing the Impact of an FDA Panel’s 12 to 1 Vote to Withdraw Avastin’s Marketing Approval for Breast Cancer - On Demand
  July 29, 2010
  Based on our Pharmacor advisory service entitled Breast Cancer, Decision Resources is offering an exclusive analyst call entitled A Crushing Blow for Avastin? Assessing the Impact of an FDA Panel’s 12 to 1 Vote to Withdraw Avastin’s Marketing Approval for Breast Cancer. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  This analyst call was held on July 29, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
   
  
  Read More
• Payer Perspectives of Biosimilars: Priorities, Barriers to Entry and Opportunities - On Demand
  July 27, 2010
  As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive analyst call entitled Payer Perspectives of Biosimilars: Priorities, Barriers to Entry and Opportunities. This analyst call is open ONLY to subscribers of Decision Resources’ Biosimilars Advisory Service.
  
  This analyst call was held on July 27, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
  
  
  Read More
• Venous Thromboembolism: How Will Sanofi-Aventis’s Semuloparin (AVE-5026) Compete in a Market That Will Soon Feature a Range of Oral Anticoagulants? - On Demand
  July 26, 2010
  Based on our Pharmacor Venous Thromboembolism advisory service, Decision Resources is offering an exclusive analyst call entitled Venous Thromboembolism: How Will Sanofi-Aventis’s Semuloparin (AVE-5026) Compete in a Market That Will Soon Feature a Range of Oral Anticoagulants? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  This analyst call was held on July 26, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
  
  
  Read More
• How Will Key Agents in Development Impact the Type 2 Diabetes Market? News from the ADA’s 70th Annual Scientific Sessions - On Demand
  July 15, 2010
  Based on our Pharmacor Type 2 Diabetes advisory service, Decision Resources is offering an exclusive analyst call entitled How Will Key Agents in Development Impact the Type 2 Diabetes Market? News from the ADA’s 70th Annual Scientific Sessions. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
  
  This analyst call was held on July 15, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
  
  Click here to view the invite.
   
  Read More
Displaying results 1-10 (of 59)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|